1. Home
  2. Animal Drug Index - B
  3. Bmd Soluble

Animal NDC 54771-1320-1 Bmd Soluble

Bacitracin Methylene Disalicylate

Animal Product Information

Field Name Field Value
Animal NDC Code 54771-1320-1
Proprietary Name Bmd Soluble What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Bacitracin Methylene Disalicylate What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Zoetis Inc.
Product Type Otc Type A Medicated Article Animal Drug
Usage Information
    Animal Condition Prevention Control Broiler and replacement chickens Necrotic enteritis caused by Clostridium perfringens susceptible to bacitracin methylenedisalicylate. 100 mg / gal 200 - 400 mg / gal Growing turkeys Transmissible enteritis (blue comb, mud fever) complicated by organisms susceptible to bacitracin methylenedisalicylate. - 400 mg / gal Growing quail Ulcerative enteritis due to Clostridium colinum susceptible to bacitracin methylenedisalicylate.. 400 mg / gal - Swine Swine dysentery (bloody scours) associated with Brachyspira hyodysenteriae. - 1000 mg / gal
Active Ingredient(s)
  • Bacitracin Methylenedisalicylate
Marketing Category NADA - NEW ANIMAL DRUG APPLICATION What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
FDA Application Number NADA065470 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Bmd Soluble Images

Bmd Soluble Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Broiler And Replacement Chickens



An aid in prevention and control of necrotic enteritis caused by Clostridium perfringens susceptible to bacitracin methylenedisalicylate.


Growing Turkeys



An aid in control of transmissible enteritis (blue comb, mud fever) in growing turkeys complicated by organisms susceptible to bacitracin methylenedisalicylate.


Growing Quail



For the prevention of ulcerative enteritis due to Clostridium colinum susceptible to bacitracin methylenedisalicylate.


Swine



For use in the treatment of swine dysentery associated with Brachyspira hyodysenteriae.


Active Ingredient



Contains 51.2 g bacitracin activity from bacitracin methylenedisalicylate equivalent to 200 g bacitracin activity per pound or to 18,520 units bacitracin (master standard) per gram.


Ingredients



Granulated sugar, sodium bicarbonate, anti-caking agent.


Caution



Not for use in humans. Keep out of reach of children.
For oral use in animals only.


Concentrated



For water medicators.


Directions For Use



Animal Condition Prevention Control
 Broiler and replacement chickens Necrotic enteritis caused by Clostridium perfringens susceptible to bacitracin methylenedisalicylate. 100 mg / gal 200 - 400 mg / gal
 Growing turkeys Transmissible enteritis (blue comb, mud fever) complicated by organisms susceptible to bacitracin methylenedisalicylate. - 400 mg / gal
 Growing quail Ulcerative enteritis due to Clostridium colinum susceptible to bacitracin methylenedisalicylate.. 400 mg / gal -
 Swine Swine dysentery (bloody scours) associated with Brachyspira hyodysenteriae. - 1000 mg / gal

For Proportioners



Select the treatment dosage. Set the proportioner at the desired delivery rate. To prepare the proportioner's stock solution, place the indicated quantity of BMD Soluble in a 2-gallon container, fill with water and stir until dissolved.


For Tanks



One package of BMD Soluble will medicate approximately 50 gallons of water at a dosage of 1000 mg/gallon.

Treatment dosage PROPORTIONER SET AT:
1 ounce/gallon		 PROPORTIONER SET AT:
2 ounces/gallon
 100 mg/gal 1/2 pack 1/4 pack
 200 mg/gal

200 mg/gallon is equivalent to about 100 g of feed grade BMD per ton of feed

 1 pack 1/2 pack
 400 mg/gal 2 packs 1 pack
 1000 mg/gal 5 packs 2-1/2 packs

 *200 mg/gallon is equivalent to about 100 g of feed grade BMD per ton of feed

To control an outbreak, start medication at first clinical signs of disease. Consult a diagnostic laboratory or veterinarian to determine the diagnosis and advice regarding the optimal level of drug. For necrotic enteritis in broiler and replacement chickens, administer continuously 5-7 days or as long as clinical signs persist, then reduce medication to prevention levels (100 mg/gal).

For transmissible enteritis in turkeys, administer continuously as long as clinical signs persist. For swine dysentery start medication at first signs of the disease or at time of exposure and administer continuously for 7 days or until signs of dysentery disappear. Treatment not to exceed 14 days.

CAUTION: Not for use in swine weighing more than 250 lb.


Principal Display Panel - Bag Label





* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.